Literature DB >> 21844448

Successful treatment of subacute lupus erythematosus with ustekinumab.

Aieska De Souza1, Trisha Ali-Shaw, Bruce E Strober, Andrew G Franks.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21844448     DOI： 10.1001/archdermatol.2011.185

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN： 0003-987X


× No keyword cloud information.
  17 in total

Review 1.  Janus-like effects of type I interferon in autoimmune diseases.

Authors:  Robert C Axtell; Chander Raman
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

Review 2.  Beyond pan-B-cell-directed therapy - new avenues and insights into the pathogenesis of SLE.

Authors:  Thomas Dörner; Peter E Lipsky
Journal:  Nat Rev Rheumatol       Date:  2016-10-13       Impact factor: 20.543

Review 3.  Therapeutic options for cutaneous lupus erythematosus: recent advances and future prospects.

Authors:  Joshua Chang; Victoria P Werth
Journal:  Expert Rev Clin Immunol       Date:  2016-06-01       Impact factor: 4.473

Review 4.  T cells and IL-17 in lupus nephritis.

Authors:  Tomohiro Koga; Kunihiro Ichinose; George C Tsokos
Journal:  Clin Immunol       Date:  2016-04-21       Impact factor: 3.969

Review 5.  The continuing evolution of targeted therapy for inflammatory skin disease.

Authors:  C Schlapbach; A A Navarini
Journal:  Semin Immunopathol       Date:  2015-09-30       Impact factor: 9.623

6.  IL-17 and IL-23 in lupus nephritis - association to histopathology and response to treatment.

Authors:  Agneta Zickert; Petra Amoudruz; Yvonne Sundström; Johan Rönnelid; Vivianne Malmström; Iva Gunnarsson
Journal:  BMC Immunol       Date:  2015-02-12       Impact factor: 3.615

7.  Hidradenitis suppurativa associated with systemic lupus erythematosus: A case report.

Authors:  Chen Ben David; Nicola L Bragazzi; Abdulla Watad; Kassem Sharif; Aaron Whitby; Howard Amital; Mohammad Adawi
Journal:  Medicine (Baltimore)       Date:  2018-03       Impact factor: 1.889

Review 8.  Alternative uses of ustekinumab for non-indicated dermatological conditions: a systematic review.

Authors:  Sahil Rawal; Sara Kianian; William Guo; Jocellie Marquez; Marissa Ayasse; Katherine A Siamas; Yoojin Lee; Joann Salvemini
Journal:  Arch Dermatol Res       Date:  2021-06-22       Impact factor: 3.017

9.  Emerging dermatological and systemic applications of ustekinumab: beyond its clinical use in psoriasis.

Authors:  Shailendra Kapoor
Journal:  Clin Cosmet Investig Dermatol       Date:  2012-06-21

10.  Cytokines and Effector/Regulatory Cells Characterization in the Physiopathology of Cutaneous Lupus Erythematous: A Cross-Sectional Study.

Authors:  Silvia Méndez-Flores; Gabriela Hernández-Molina; Ana Bety Enríquez; David Faz-Muñoz; Yeraldin Esquivel; Carlos Pacheco-Molina; Janette Furuzawa-Carballeda
Journal:  Mediators Inflamm       Date:  2016-03-06       Impact factor: 4.711
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.